124 related articles for article (PubMed ID: 14663549)
1. Hyperthermic and neurotoxic effect of 3,4-methylenedioxymethamphetamine (MDMA) in guinea pigs.
Saadat KS; Elliott JM; Colado MI; Green AR
Psychopharmacology (Berl); 2004 May; 173(3-4):452-3. PubMed ID: 14663549
[No Abstract] [Full Text] [Related]
2. MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat.
Clemens KJ; Van Nieuwenhuyzen PS; Li KM; Cornish JL; Hunt GE; McGregor IS
Psychopharmacology (Berl); 2004 May; 173(3-4):318-25. PubMed ID: 15029472
[TBL] [Abstract][Full Text] [Related]
3. Effect of acute brain tyrosine depletion on MDMA-induced changes in brain 5-HT.
Rodsiri R; Green AR; Marsden CA; Fone KC
J Psychopharmacol; 2010 Feb; 24(2):267-74. PubMed ID: 19965941
[TBL] [Abstract][Full Text] [Related]
4. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR
J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986
[TBL] [Abstract][Full Text] [Related]
5. Unilateral infusion of a dopamine transporter antisense into the substantia nigra protects against MDMA-induced serotonergic deficits in the ipsilateral striatum.
Kanthasamy A; Sprague JE; Shotwell JR; Nichols DE
Neuroscience; 2002; 114(4):917-24. PubMed ID: 12379247
[TBL] [Abstract][Full Text] [Related]
6. Studies on striatal neurotoxicity caused by the 3,4-methylenedioxymethamphetamine/ malonate combination: implications for serotonin/dopamine interactions.
Goñi-Allo B; Ramos M; Herv'as I; Lasheras B; Aguirre N
J Psychopharmacol; 2006 Mar; 20(2):245-56. PubMed ID: 16510482
[TBL] [Abstract][Full Text] [Related]
7. Effect of ambient temperature and a prior neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated ('binge' ingestion) low dose of MDMA.
Green AR; Sanchez V; O'Shea E; Saadat KS; Elliott JM; Colado MI
Psychopharmacology (Berl); 2004 May; 173(3-4):264-9. PubMed ID: 14726996
[TBL] [Abstract][Full Text] [Related]
8. A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain.
Colado MI; Camarero J; Mechan AO; Sanchez V; Esteban B; Elliott JM; Green AR
Br J Pharmacol; 2001 Dec; 134(8):1711-23. PubMed ID: 11739248
[TBL] [Abstract][Full Text] [Related]
9. 3,4-Methylenedioxymethamphetamine administration on postnatal day 11 in rats increases pituitary-adrenal output and reduces striatal and hippocampal serotonin without altering SERT activity.
Williams MT; Schaefer TL; Ehrman LA; Able JA; Gudelsky GA; Sah R; Vorhees CV
Brain Res; 2005 Mar; 1039(1-2):97-107. PubMed ID: 15781051
[TBL] [Abstract][Full Text] [Related]
10. (+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals.
Ricaurte GA; Yuan J; McCann UD
Neuropsychobiology; 2000; 42(1):5-10. PubMed ID: 10867550
[TBL] [Abstract][Full Text] [Related]
11. Ethanol and MDMA: a comment on the paper by Izco et al.
Jones BC; Cassel JC
Psychopharmacology (Berl); 2007 Apr; 191(2):387-8. PubMed ID: 17265072
[No Abstract] [Full Text] [Related]
12. DNA damage and ubiquitinated neuronal inclusions in the substantia nigra and striatum of mice following MDMA (ecstasy).
Fornai F; Lenzi P; Frenzilli G; Gesi M; Ferrucci M; Lazzeri G; Biagioni F; Nigro M; Falleni A; Giusiani M; Pellegrini A; Blandini F; Ruggieri S; Paparelli A
Psychopharmacology (Berl); 2004 May; 173(3-4):353-63. PubMed ID: 14673567
[TBL] [Abstract][Full Text] [Related]
13. Neuropharmacology and neurotoxicity of 3,4-methylenedioxymethamphetamine.
Gudelsky GA; Yamamoto BK
Methods Mol Med; 2003; 79():55-73. PubMed ID: 12506690
[TBL] [Abstract][Full Text] [Related]
14. Serotonergic neurotoxicity of 3,4-(+/-)-methylenedioxyamphetamine and 3,4-(+/-)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of gamma-glutamyl transpeptidase.
Bai F; Jones DC; Lau SS; Monks TJ
Chem Res Toxicol; 2001 Jul; 14(7):863-70. PubMed ID: 11453733
[TBL] [Abstract][Full Text] [Related]
15. Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity.
Pubill D; Canudas AM; Pallàs M; Camins A; Camarasa J; Escubedo E
Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):490-9. PubMed ID: 12684743
[TBL] [Abstract][Full Text] [Related]
16. Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research.
Curran HV
Neuropsychobiology; 2000; 42(1):34-41. PubMed ID: 10867554
[TBL] [Abstract][Full Text] [Related]
17. MDMA-induced serotonergic neurotoxicity enhances aggressiveness in low- but not high-aggressive rats.
Wallinga AE; ten Voorde AM; de Boer SF; Koolhaas JM; Buwalda B
Eur J Pharmacol; 2009 Sep; 618(1-3):22-7. PubMed ID: 19616536
[TBL] [Abstract][Full Text] [Related]
18. Aged rats are more vulnerable than adolescents to "ecstasy"-induced toxicity.
Feio-Azevedo R; Costa VM; Barbosa DJ; Teixeira-Gomes A; Pita I; Gomes S; Pereira FC; Duarte-Araújo M; Duarte JA; Marques F; Fernandes E; Bastos ML; Carvalho F; Capela JP
Arch Toxicol; 2018 Jul; 92(7):2275-2295. PubMed ID: 29869127
[TBL] [Abstract][Full Text] [Related]
19. Cocaine potentiates MDMA-induced oxidative stress but not dopaminergic neurotoxicity in mice: implications for the pathogenesis of free radical-induced neurodegenerative disorders.
Peraile I; Granado N; Torres E; Gutiérrez-López MD; Moratalla R; Colado MI; O'Shea E
Psychopharmacology (Berl); 2013 Nov; 230(1):125-35. PubMed ID: 23681166
[TBL] [Abstract][Full Text] [Related]
20. Effect of depleting vesicular and cytoplasmic dopamine on methylenedioxymethamphetamine neurotoxicity.
Yuan J; Cord BJ; McCann UD; Callahan BT; Ricaurte GA
J Neurochem; 2002 Mar; 80(6):960-9. PubMed ID: 11953446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
